{"ticker": {"uuid": "198c7784-e28a-41e8-8ee1-7801df77e80d", "symbol": "603439", "name": "Guizhou Sanli Pharmaceutical Co.,Ltd", "exchange": "SHH", "country": "CN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Enterprise value to EBIT forward of GuiZhou SanLi Pharmaceutical Co., Ltd. Class A \u2013 SSE:603439", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOSmRfS1hyenl1Uno3eWdTek9BS2hOS01rT3RkR3VSRmRZLVd4WWRFYnh1MmxNS3ZlMFZjQU1ESUJuc21Pb0ZlRmE3YWhMblc5OHd3M0pUd1BLNnRTeDMwYzl6ajVNeEc0cWVjS0dENVdRbEhyUmtsVEtKWVVpdi1lbC05UlFWQ0c0QU5PalVNQUI3SDREakNRRWtZdUUxaFR2ZTY1Y0hacFI2Zw?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T19:55:25+00:00", "published_display": "12 Jul 2026 19:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of GuiZhou SanLi Pharmaceutical Co., Ltd. Class A \u2013 SSE:603439", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPdjhMcUFiYlJFSmNzemFnRzNvT1Zyb0VYUFlLSHpKdjhUYkFUM1Nlc2NsbmNTLTU5RTFwOXZlRE94amtteTFkakJaTDI3dUdwWllqVHlueS1lOHBBZjN0X3JkSXU2U3o2UG5wSWJOQlhCbFptMm1nV1pSRmZpZVJUZGdNVFlZVGV0ZHhyakk2NVNUbHpVN1pISTJqTQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T18:11:04+00:00", "published_display": "12 Jul 2026 18:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Enterprise value to EBIT forward of GuiZhou SanLi Pharmaceutical Co., Ltd. Class A \u2013 SSE:603439", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOSmRfS1hyenl1Uno3eWdTek9BS2hOS01rT3RkR3VSRmRZLVd4WWRFYnh1MmxNS3ZlMFZjQU1ESUJuc21Pb0ZlRmE3YWhMblc5OHd3M0pUd1BLNnRTeDMwYzl6ajVNeEc0cWVjS0dENVdRbEhyUmtsVEtKWVVpdi1lbC05UlFWQ0c0QU5PalVNQUI3SDREakNRRWtZdUUxaFR2ZTY1Y0hacFI2Zw?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T19:55:25+00:00", "published_display": "12 Jul 2026 19:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of GuiZhou SanLi Pharmaceutical Co., Ltd. Class A \u2013 SSE:603439", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPdjhMcUFiYlJFSmNzemFnRzNvT1Zyb0VYUFlLSHpKdjhUYkFUM1Nlc2NsbmNTLTU5RTFwOXZlRE94amtteTFkakJaTDI3dUdwWllqVHlueS1lOHBBZjN0X3JkSXU2U3o2UG5wSWJOQlhCbFptMm1nV1pSRmZpZVJUZGdNVFlZVGV0ZHhyakk2NVNUbHpVN1pISTJqTQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T18:11:04+00:00", "published_display": "12 Jul 2026 18:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 40, "total_relevant": 2, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 2, "score": 50, "total": 2, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 75, "events": [{"event": "general", "label": "Market update", "weight": 1.1, "count": 2}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 10.95, "latest_week": "2026-07-17", "one_week_move": -8.6, "four_week_move": -29.7, "twelve_week_move": 0.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.283874, "market_dynamics_buy_signal": false, "relative_strength": -8.172655, "fair_value_gap": -19.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 50.5047, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-8.6% over one week, -29.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 56, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-8.6% over one week, -29.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Enterprise value to EBIT forward of GuiZhou SanLi Pharmaceutical Co., Ltd. Class A \u2013 SSE:603439"}], "updated_at": "2026-07-23T05:29:34.227260+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}